These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25382691)

  • 1. The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder.
    Hung CI; Liu CY; Chen CY; Yang CH; Wang SJ
    J Headache Pain; 2014 Nov; 15(1):73. PubMed ID: 25382691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine with active headache was associated with other painful physical symptoms at two-year follow-up among patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH; Wang SJ
    PLoS One; 2019; 14(4):e0216108. PubMed ID: 31039196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impacts of Migraine among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up.
    Hung CI; Liu CY; Yang CH; Wang SJ
    PLoS One; 2015; 10(5):e0128087. PubMed ID: 26000962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine and greater pain symptoms at 10-year follow-up among patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH; Wang SJ
    J Headache Pain; 2018 Jul; 19(1):56. PubMed ID: 30019214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH; Wang SJ
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):8-16. PubMed ID: 22250605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headache: an important factor associated with muscle soreness/pain at the two-year follow-up point among patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH; Wang SJ
    J Headache Pain; 2016; 17():57. PubMed ID: 27233897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of anxiety and migraine on quality of sleep in patients with major depressive disorder.
    Hsu SC; Wang SJ; Liu CY; Juang YY; Yang CH; Hung CI
    Compr Psychiatry; 2009; 50(2):151-7. PubMed ID: 19216892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impacts of migraine, anxiety disorders, and chronic depression on quality of life in psychiatric outpatients with major depressive disorder.
    Hung CI; Wang SJ; Yang CH; Liu CY
    J Psychosom Res; 2008 Aug; 65(2):135-42. PubMed ID: 18655858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine: a missing link between somatic symptoms and major depressive disorder.
    Hung CI; Liu CY; Cheng YT; Wang SJ
    J Affect Disord; 2009 Sep; 117(1-2):108-15. PubMed ID: 19167091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G; Frare F; Toni C; Ruffolo G; Torti C
    Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of migraine on patients with major depressive disorder.
    Hung CI; Liu CY; Juang YY; Wang SJ
    Headache; 2006 Mar; 46(3):469-77. PubMed ID: 16618265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major depressive disorder severity and the frequency of painful physical symptoms: a pooled analysis of observational studies.
    Brnabic A; Lin C; Monkul ES; Dueñas H; Raskin J
    Curr Med Res Opin; 2012 Dec; 28(12):1891-7. PubMed ID: 23145858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of venlafaxine extended-release monotherapy for first-episode depression with painful physical symptoms.
    Huang X; Li C; Luo YL; Wang B; Ji JL
    Neuroreport; 2013 May; 24(7):364-9. PubMed ID: 23511776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pain syndromes with venlafaxine.
    Grothe DR; Scheckner B; Albano D
    Pharmacotherapy; 2004 May; 24(5):621-9. PubMed ID: 15162896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities and factors related to discontinuation of pharmacotherapy among outpatients with major depressive disorder.
    Hung CI; Wang SJ; Liu CY; Hsu SC; Yang CH
    Compr Psychiatry; 2011; 52(4):370-7. PubMed ID: 21683174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid anxiety in late-life depression: Relationship with remission and suicidal ideation on venlafaxine treatment.
    Saade YM; Nicol G; Lenze EJ; Miller JP; Yingling M; Wetherell JL; Reynolds CF; Mulsant BH
    Depress Anxiety; 2019 Dec; 36(12):1125-1134. PubMed ID: 31682328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study.
    Ang QQ; Wing YK; He Y; Sulaiman AH; Chiu NY; Shen YC; Wang G; Zhang C; Lee KH; Singh P; Granger RE; Raskin J; Dossenbach M
    Int J Clin Pract; 2009 Jul; 63(7):1041-9. PubMed ID: 19570122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
    Leuchter AF; Husain MM; Cook IA; Trivedi MH; Wisniewski SR; Gilmer WS; Luther JF; Fava M; Rush AJ
    Psychol Med; 2010 Feb; 40(2):239-51. PubMed ID: 19493369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
    Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
    Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of painful physical symptoms on first-episode major depressive disorder in adults with subthreshold depressive symptoms: A prospective cohort study.
    Li X; Zhang H; Wu K; Fan B; Guo L; Liao Y; McIntyre RS; Wang W; Liu Y; Shi J; Chen Y; Shen M; Wang H; Li L; Han X; Lu C
    Gen Hosp Psychiatry; 2024; 86():1-9. PubMed ID: 38029479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.